DA 9601: Clinical Trials

7 trials of DA 9601, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 not yet recruiting, 1 unknown. 4 Phase 4, 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 44Completed 3, Not yet recruiting 1
Phase 32Completed 1, Unknown 1
Phase 21Completed 1

Follow DA 9601: new trials by email Literature Review of DA 9601 trials Research Report on DA 9601

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 4 Study of Sto M Tab. in Acute or Chronic Gastritis
Stillen Tab., Sto M Tab. - Gastritis, Acute Gastritis
Phase 4Not yet recruitingMather's Pharm. Co., Ltd.4702026-06-012026-06-05
Clinical Trial to Evaluate the Efficacy and Safety of DA-5219 in Patients With Acute or Chronic Gastritis
DA-5219, StillenĀ® Tab, DA-5219 Placebo - Gastritis Acute, Gastritis Chronic
Phase 3CompletedDong-A ST Co., Ltd.4672024-01-312025-08-28
Efficacy and Safety of Eupasidin-s Tab.(EUPASIDIN-S) in Gastritis Patients
Eupasidin-s Tab, Stillen Tab. - Acute Gastritis, Chronic Gastritis
Phase 4CompletedChong Kun Dang Pharmaceutical2302014-08-012015-08-24
A Study to Evaluate the Efficacy and Safety of DA-5204
DA-5204, Stillen tab. - Acute Gastritis, Chronic Gastritis
Phase 3UnknownDong-A ST Co., Ltd.4342014-04-012014-11-04
A Study to Evaluate the Efficacy and of Stillen Tab. and to Demonstrate the Non-inferiority of Stillen Tab.
Stillen Tab., Mucosta Tab. - Acute Gastritis, Chronic Gastritis
Phase 4CompletedDong-A ST Co., Ltd.2582012-10-012021-04-15
A Multicenter, Double Blinded, Randomized, Parallel Assignment Study to Demonstrate the Efficacy of DA9601
Stillen, Cytotec (reference drug), NSAID (Aceclofenac) - NSAID-associated Gastroduodenal Injury
Phase 4CompletedDong-A ST Co., Ltd.5202012-09-012014-09-30
A Study to Evaluate the Safety and Efficacy of DA9601 for Acute and Chronic Gastritis and to Determine the Optimal Clinical Dosage and Administration
StillenĀ® Tab, StillenĀ® Tab Placebo - Acute Gastritis, Chronic Gastritis
Phase 2CompletedDong-A ST Co., Ltd.2121997-03-142025-08-29

Conditions studied

Gastritis (1)

Sponsors

Dong-A ST Co., Ltd. (5)  ·  Chong Kun Dang Pharmaceutical (1)  ·  Mather's Pharm. Co., Ltd. (1)

Countries

South Korea (6)

Top investigators

Dae Hwan Kang, M.D., Ph.D. (2)  ·  Yong Chan Lee, M.D., Ph.D. (2)  ·  Byung Ik Jang, MD (1)  ·  Dong Ho Lee, M.D., Ph.D. (1)  ·  Dong Ho Lee, MD (1)  ·  Dong Il Park, M.D., Ph.D. (1)  ·  Dong Soo Han, MD (1)  ·  Eun Kwang Choi, M.D., Ph.D. (1)  ·  Geun Am Song, M.D., Ph.D. (1)  ·  Geunam Song, MD (1)  ·  Gi Nam Sim, M.D., Ph.D. (1)  ·  Hoon-jai Chun, MD (1)  ·  Hwoon Yong Jung, M.D., Ph.D. (1)  ·  Hyen Soo Kim, M.D., Ph.D. (1)  ·  Hyo Jin Park, MD (1)

Results publications

PMID 28960033